Sumiting, Lino C.
HRN: 22 35 31 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/23/2022
CEFUROXIME 1.5GM (VIAL)
12/23/2022
12/30/2022
INTRAVENOUS
750 Mg
Q8h
Open Fracture
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes